ReviewEBioMedicine2022

Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy.

Honggang Ying et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.